Defunct Company
Total Trials
28
As Lead Sponsor
27
As Collaborator
1
Total Enrollment
2,588
NCT00708526
Improved Patient Recovery After Anesthesia With Hypercapnia Hyperpnoea
Phase: N/A
Role: Collaborator
Start: Mar 31, 2008
Completion: Nov 30, 2008
NCT04349683
Efficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to Glomerulonephritis
Phase: Phase 4
Role: Lead Sponsor
Start: Apr 30, 2020
Completion: Oct 30, 2021
NCT05449535
Study of JYB1904 (an Anti-immunoglobulin E Antibody) in Healthy Chinese Subjects
Phase: Phase 1
Start: May 7, 2022
Completion: Jan 10, 2023
NCT05907382
Safety, Tolerability of JMKX003002 in Phase 1 Study in Healthy Subjects
Start: May 9, 2023
Completion: Mar 31, 2024
NCT05923515
A Phase I Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion
Start: May 22, 2023
Completion: May 1, 2025
NCT06880848
Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in China
Start: Jun 21, 2023
Completion: Aug 26, 2025
NCT06079541
Phase 1 Clinical Study of JMKX003142 Tablets
Start: Jul 6, 2023
Completion: Mar 30, 2025
NCT05821595
JYB1907 in Subjects With Advanced Solid Tumors
Start: Jul 31, 2023
Completion: Oct 31, 2024
NCT06066060
A DDI Study of JMKX000623 and Metformin Hydrochloride
Start: Sep 17, 2023
Completion: Nov 6, 2023
NCT05967520
JMKX000189 for Moderate to Severe Active Systemic Lupus Erythematosus
Phase: Phase 2
Start: Sep 21, 2023
Completion: Dec 31, 2025
NCT06321250
A Study of JMKX003948 Tablets in Patients With Renal Cell Carcinoma
Start: Mar 14, 2024
Completion: Apr 30, 2027
NCT06221241
Evaluate the Efficacy and Safety of JMKX000623 in Participants With Diabetic Peripheral Neuropathic Pain
Start: Mar 25, 2024
Completion: Apr 30, 2025
NCT06348290
Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects
Start: Apr 1, 2024
Completion: Sep 15, 2024
NCT06344533
Study of JMKX003142 Injection in Chinese Healthy Subjects
Start: Apr 10, 2024
Completion: May 30, 2025
NCT06438757
Trial of JYB1904 in Patients With Allergic Asthma
Start: Jun 19, 2024
Completion: Oct 31, 2025
NCT06473948
To Assess the Effects of Single Dose of JMKX001899 on QTc Interval in Healthy Subjects
Start: Jul 10, 2024
Completion: Feb 27, 2025
NCT06509334
Trial of JYB1904 in Chronic Spontaneous Urticaria.
Start: Aug 4, 2024
Completion: Jul 15, 2026
NCT06549309
Trial of JMKX003801 in Healthy Participants
Start: Aug 17, 2024
Completion: Jun 12, 2025
NCT06658964
Study to Evaluate the Drug-drug Interaction of JMKX003142 in Healthy Subjects
Start: Nov 5, 2024
Completion: Mar 21, 2025
NCT06740019
A Phase Ib Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion
Start: Dec 28, 2024
Completion: Nov 30, 2026
NCT06664125
Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with Hyperphosphatemia
Start: Dec 30, 2024
Completion: Sep 30, 2025
NCT06670534
A Dose-finding Study of JMKX003142 in Treatment of Renal Edema
Start: Jan 7, 2025
Completion: Jul 30, 2026
NCT06832657
Study of JMKX003948 Ophthalmic Suspension in Healthy Participants
Start: Feb 28, 2025
NCT06800651
Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Start: Mar 13, 2025
Completion: May 30, 2027
NCT06949020
A Dose-finding Study of JMKX003142 in Treatment of Cardiac Edema
Start: Jun 1, 2025
Completion: May 31, 2027
NCT06946927
A Phase Ib Study of JMKX001899 in Combination With Other Therapies in Advanced NSCLC Harboring KRAS G12C Mutation
Start: Jun 6, 2025
Completion: Dec 31, 2027
NCT07181265
Drug-Drug Interaction of JMKX003142 With Amiodarone and Febuxostat in Healthy Subjects
Start: Oct 30, 2025
Completion: Jun 30, 2026
NCT07208136
A Study of JMKX005425 in Patients With MSI-H/dMMR Advanced Solid Tumors
Start: Oct 31, 2025
Completion: Dec 31, 2028